Ondansetron ODT 4 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FYQNL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,525
Award facts
- Contract value 100% obligated
- $4,525.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $4,525.13 to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count packages) on September 11, 2025, with a completion date of September 12, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Ondansetron is an antiemetic medication commonly used across military and federal healthcare systems to manage nausea and vomiting in clinical and operational settings.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, consistently serves as a critical vendor for federal medical procurement through the Defense Logistics Agency's Medical Supply Chain. The company's portfolio includes extensive federal contract awards for brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic areas. This delivery order continues AmerisourceBergen's role in supplying essential pharmaceutical products to support military healthcare programs and other federal healthcare systems, demonstrating the company's established capability to fulfill federal procurement requirements through open competition without set-aside designations.
Quick answers
Who was awarded contract SPE2DB25FYQNL?
SPE2DB25FYQNL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 11, 2025.
How much is contract SPE2DB25FYQNL worth?
The government has obligated $4,525 on SPE2DB25FYQNL.
Is contract SPE2DB25FYQNL an order under another contract?
Yes. SPE2DB25FYQNL is a delivery order under SPE2DB22D1017, an indefinite delivery contract.
Was contract SPE2DB25FYQNL competed?
The extent of competition for SPE2DB25FYQNL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award